The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: a pooled analysis

被引:0
|
作者
Qu, M. X. [1 ]
Velker, V. [2 ]
Leung, E. [3 ]
Kwon, J. [4 ]
Elshaikh, M. A. [5 ]
Kong, I. [6 ]
Logie, N. [7 ]
Mendez, L. C. [3 ]
Van der Putten, L. [4 ]
Donovan, E. [6 ]
Munkarah, A. R. [8 ]
Wiebe, E. M. [7 ]
Louie, A. V. [2 ]
D'Souza, D. P. [2 ]
机构
[1] Queens Univ, Oncol, Kingston, ON, Canada
[2] Western Univ, Radiat Oncol, London, ON, Canada
[3] Univ Toronto, Radiat Oncol, Toronto, ON, Canada
[4] Univ British Columbia, Obstet & Gynaecol, Vancouver, BC, Canada
[5] Henry Ford Hosp, Radiat Oncol, Detroit, MI 48202 USA
[6] McMaster Univ, Oncol, Hamilton, ON, Canada
[7] Univ Alberta, Oncol, Edmonton, AB, Canada
[8] Henry Ford Hosp, Gynecol Oncol, Detroit, MI 48202 USA
关键词
D O I
10.1016/S0167-8140(17)30988-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PV-0548
引用
收藏
页码:S292 / S292
页数:1
相关论文
共 50 条
  • [1] The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis
    Qu, X. Melody
    Velker, Vikram M.
    Leung, Eric
    Kwon, Janice S.
    Elshaikh, Mohamed A.
    Kong, Iwa
    Logie, Natalie A.
    Mendez, Lucas C.
    van der Putten, Louis J.
    Donovan, Elysia K.
    Munkarah, Adnan R.
    Wiebe, Ericka M.
    Parra-Herran, Carlos
    Warner, Andrew
    Louie, Alexander, V
    D'Souza, David P.
    GYNECOLOGIC ONCOLOGY, 2018, 149 (02) : 283 - 290
  • [2] The role of adjuvant therapy for stage IA serous and clear cell uterine cancer; is observation a valid strategy?
    Prefontaine, Michel
    Velker, Vikram
    D'Souza, David
    Leung, Eric
    GYNECOLOGIC ONCOLOGY, 2015, 139 (03) : 589 - 589
  • [3] Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
    Velker, Vikram
    D'Souza, David
    Prefontaine, Michel
    McGee, Jacob
    Leung, Eric
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (03) : 491 - 496
  • [4] Improved Disease Control With Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: A Pooled Multi-institutional Analysis
    Qu, M. X.
    Velker, V.
    Leung, E. W.
    Kwon, J.
    Elshaikh, M. A.
    Kong, I.
    Logie, N.
    Mendez, L. C.
    van der Putten, L.
    Donovan, E.
    Munkarah, A. R.
    Wiebe, E. M.
    Louie, A. V.
    D'Souza, D. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S229 - S229
  • [5] Is adjuvant therapy necessary for Stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
    Kwon, J. S.
    Abrams, J.
    Sugimoto, A.
    Carey, M. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (04) : 820 - 824
  • [6] Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
    Lefebvre, Manon
    Duchatelet, Mathilde
    Hajj, Houssein El
    Courreges, Antoine De
    Wallet, Jennifer
    Bellier, Charlotte
    Tinier, Florence Le
    Deley, Marie Cecile Le
    Gomez, Carlos Martinez
    Leblanc, Eric
    Narducci, Fabrice
    Hudry, Delphine
    CURRENT ONCOLOGY, 2023, 30 (01) : 1174 - 1185
  • [7] Optimal adjuvant therapy and outcomes for early-stage uterine serous and clear cell carcinoma
    McEachron, Jennifer
    Zhou, Nancy
    Bennett, Michelle
    Hastings, Victoria
    Kanis, Margaux
    Gorelick, Constantine
    Lee, Yi-Chun
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S221 - S221
  • [8] Adjuvant therapy for Stage IA uterine clear cell carcinoma with no myometrial invasion: a critical review of literature
    Desteli, G. A.
    Dogan, N. U.
    Gursu, T.
    Ayhan, A.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (01) : 17 - 21
  • [9] Adjuvant treatment and impact on relapse in stage IA uterine papillary serous and clear cell carcinomas: A single center retrospective study
    Khurana, S.
    Kalra, K.
    Malik, P. S.
    Sharma, D.
    Pramanik, R.
    Bhatla, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S1591 - S1592
  • [10] Limiting adjuvant chemotherapy in stage IA uterine papillary serous carcinoma
    Goodwin, Halle
    Mujumdar, Vaidehi
    Chen, Jane
    Brown, Jubilee
    Crane, Erin
    Lees, Brittany
    Puechl, Allison
    Casablanca, Yovanni
    Naumann, R. Wendel
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S431 - S431